OR WAIT 15 SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
Jim Greenwood is president and CEO of the Biotechnology Innovation Organization (BIO). He represented Pennsylvania’s 8thÂ district in the US House of Representatives from 1993 to 2005.
New reports indicate that drug prices are slowing compared to other healthcare costs.
Policies for patient access to life-saving therapies must keep pace with biomedical innovation.
Protecting intellectual property rights is vital to biopharmaceutical innovation.
Sound policies are needed to govern the substitution of interchangeable biologics.